Position in OGN
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$3,294
New position
Shares Held
550
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WAYCROSS PARTNERS, LLC holds $44,812,679 across 6 Drug Manufacturers - General names.
All Filings in OGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,294 | 550 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||